1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
USAID Act to End NTDs | East program is sponsored by U.S. Agency for International Development (USAID). This program supports countries in Africa, Asia, and Latin America to achieve targets for controlling and eliminating neglected tropical diseases including schistosomiasis. It focuses on delivering treatments, monitoring progress, and ensuring health systems can sustain NTD services.
The program aims to advance toward World Health Organization global NTD goals, including a 90% reduction in people needing interventions by 2030.
Get alerted about grants like this
Get emailed when new opportunities from “U.S. Agency for International Development (USAID)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: The program supports governments in 13 countries in Africa, Asia, and Latin America. It works with local partners and health ministries. Confirm the full requirements in the official notice before applying.
The current listing shows program ceiling increased by $125 million, for a total of more than $420 million over eight years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for USAID Act to End NTDs | East program are due September 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
USAID Act to End NTDs | East program is funded by U.S. Agency for International Development (USAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Development Innovation Ventures (DIV) Annual Program Statement is sponsored by U.S. Agency for International Development (USAID). The Development Innovation Ventures (DIV) program invites applications for innovations that address international development challenges and improve the lives of people living in poverty in developing countries. DIV provides tiered funding to pilot, test, and transition to scale innovations demonstrating evidence of impact, cost-effectiveness, and potential to scale.
USAID INTEGRITAS (INTEGRITY) is sponsored by U.S. Agency for International Development (USAID)/Indonesia. The USAID Indonesia Integrity Initiative (USAID INTEGRITAS) is a five-year program that supports the Government of Indonesia (GoI) in its corruption prevention efforts through increased community engagement and strengthening a culture of integrity in both the public and private …
USAID Advancing Food Fortification Opportunities to Reinforce Diets (USAID AFFORD) is sponsored by U.S. Agency for International Development (USAID). This global Feed the Future activity works with the private sector and other stakeholders to improve nutrition, health, and economic growth by supporting large-scale food fortification. It focuses on placing the food industry at the center of the solution, fostering collaboration between food processors, governments, and other stakeholders, and ensuring food businesses have the technical assistance, finance, and supportive ecosystem to integrate food fortification. It also emphasizes data-driven decision-making.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
USAID closure eliminated 83% of projects and 280,000 jobs worldwide. The fallout reveals hard lessons about federal funding dependency that apply to every grant-funded organization in America.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read article